Trying to separate three different claims about boldenone undecylenate: that it is the right molecule, that it is the right dose, and that it does something useful.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
Haematocrit creep is the boring one that catches people at the six week mark.
How do you separate the compound effect from the routine around it?
A certificate of analysis answers one question and gets quoted as though it answers four.
Where does the human data stop and the extrapolation begin? That is the whole thread.
Is a baseline blood test really necessary before starting something like this?
Loose evidence and no evidence are different, and people overcorrect in both directions.
Most of what is called evidence here is one person, one vial, one month.
Cold storage, light protection, date on the vial. Boring, removes half the variables.
If it needs three other compounds to notice, you have not tested the first one. Eight months in on boldenone undecylenate and it lines up.
Baseline first.
Same here.
Most of the popular protocol is borrowed from a clinical population and applied to healthy people without comment.
Baseline first. Eight months in on boldenone undecylenate and it lines up.
Nobody has ever been talked out of a stack by a stranger on the internet.
This board overrates bloodwork. A number moving is not the outcome you wanted.
Is a baseline blood test really necessary before starting something like this?